Correlating the Bethesda System for Reporting Thyroid Cytopathology with Histology and Extent of Surgery: A Review of 21,746 Patients from Four Endocrine Surgery Registries Across Two Continents
William B. Inabnet(University of Kentucky), Anders Bergenfelz(Lund University), Maurizio Iacobone(University of Padua), Lauren C. Williams(Columbia University), Julie Ann Sosa(Golden Gate University), Erik Nordenström(Lund University), Rachel Bray(Columbia University), Gerard M. Doherty(Mass General Brigham), Sebastian Aspinall(Aberdeen Royal Infirmary), Göran Wallin(Örebro University), Fausto Palazzo(Hammersmith Hospital), David Scott‐Coombes(Cardiff and Vale University Health Board), Joshua Kriger(Columbia University), Marcin Barczyński(Jagiellonian University)
Cited by 32
Related Papers
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517
Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules
|JAMA Surgery|2018|379
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
|Surgery|2011|266
European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma
|British journal of surgery|2017|220
Thyroid Carcinoma
|Journal of the National Comprehensive Cancer Network|2010|205